Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Quest Diagnostics

Quest Diagnostics's Earnings: A Preview

Quest Diagnostics (NYSE:DGX) is set to give its latest quarterly earnings report on Thursday, 2022-04-21. Here's what investors need to know before the announcement. Analysts estimate that Quest Diagnostics will report an earnings per share (EPS) of $2.97.

5 Value Stocks To Watch In The Healthcare Sector

5 Value Stocks To Watch In The Healthcare Sector

What are Value Stocks?

Analyst Ratings For Quest Diagnostics

Analyst Ratings For Quest Diagnostics

Quest Diagnostics (NYSE:DGX) has observed the following analyst ratings within the last quarter:

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Benzinga's Top Ratings Upgrades, Downgrades For April 4, 2022

Positive drug tests for U.S. workers hit highest level since 2001

Overall positivity rate last year were up around 31% from all-time lows between 2010 and 2012.

Uninsured will now pay for COVID tests

Government funding cuts to key pandemic programs forced by GOP opposition arrive as progressives in Congress renew their push for Medicare for All.

Quest Diagnostics Secures CDC Contract To Support COVID-19 Research

The Centers for Disease Control and Prevention (CDC) has granted a contract to Quest Diagnostics Inc (NYSE:DGX) to perform testing and provide laboratory data analysis to help identify patterns in SARS-COV-2 seroprevalence on a multistate basis. Quest was awarded the contract following a competitive bid. The total contract value with all options is valued…

inkl

Read news from The Economist, FT, and more,
with one subscription

This Foreboding Sign Looms Over Quest Diagnostics's Chart

This Foreboding Sign Looms Over Quest Diagnostics's Chart

If history is any guide, there may be trouble ahead for shares of Quest Diagnostics (NYSE:DGX). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

Los trabajadores que usan cannabis legalmente aún pueden perder sus trabajos

Treinta y siete estados ahora le permiten a los adultos consumir marihuana con fines médicos, recreativos o ambos. Pero, en la mayoría de esos estados, las personas pueden ser despedidas o se les puede negar un trabajo si consumen cannabis en su tiempo libre.

Tribune News Service

Workers who legally use cannabis can still lose their jobs

Thirty-seven states now allow adults to use marijuana medically, recreationally or both. But in most of those states, people can be fired or denied a job for using cannabis in their free time.

Tribune News Service

What 8 Analyst Ratings Have To Say About Quest Diagnostics

What 8 Analyst Ratings Have To Say About Quest Diagnostics

Analysts have provided the following ratings for Quest Diagnostics (NYSE:DGX) within the last quarter:

Quest Diagnostics to pay $90,000 to settle Seventh-day Adventist’s religious discrimination claim

Quest Diagnostics will pay $90,000 to settle a religious discrimination lawsuit brought by the U.S. Equal Employment Opportunity Commission on behalf of a phlebotomist working in Rockwall, Texas.

Tribune News Service

Quest Diagnostics Q4 Earnings, FY22 Reflects Lower Demand For COVID-19 Testing Services

Quest Diagnostics Q4 Earnings, FY22 Reflects Lower Demand For COVID-19 Testing Services

Quest Diagnostics Incorporated (NYSE: DGX) posted a better-than-expected

Recap: Quest Diagnostics Q4 Earnings

Recap: Quest Diagnostics Q4 Earnings

Quest Diagnostics (NYSE:DGX) reported its Q4 earnings results on Thursday, February 3, 2022 at 06:45 AM. Here's what investors need to know about the announcement.

Get all your
news in one place.

100’s of premium titles.
One news app.

Where Quest Diagnostics Stands With Analysts

Within the last quarter, Quest Diagnostics (NYSE:DGX) has observed the following analyst ratings:

Organisations

Centers for Disease Control and Prevention

Walgreens Boots Alliance

B of A Securities

Ollie Bargain Outlet

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Places

inkl

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play